Skip Ribbon Commands
Skip to main content
Menu
Dr Poh Shuxian Sharon

Dr Poh Shuxian Sharon

BDS, MD, FRCR (Clinical Oncology) (UK)

Consultant

Specialty: Radiation Oncology

Sub-specialties: Gastrointestinal Oncology, Hepato-Pancreato-Biliary, Head & Neck

Conditions Treated by this Doctor:
Laryngeal Cancer, Larynx Cancer, Nasopharyngeal Cancer (Nose Cancer), Oesophagus Cancer, Pancreatic Cancer, Stomach Cancer.

Clinical Appointments

  • Consultant Division of Radiation Oncology National Cancer Centre SingaporeNational Cancer Centre Singapore

Profile

Dr Sharon Poh is dual qualified in dental surgery as well as medicine, and obtained her MD degree from Duke-NUS Medical School in 2013. She underwent 6 years of specialist training in Radiation Oncology at the National Cancer Centre Singapore and qualified as a Fellow in Clinical Oncology from the Royal College of Radiologists (UK) in 2019.

She sub-specialises in the treatment of patients with gastrointestinal, hepato-pancreato-billary and head and neck cancers. Her research interests include gastrointestinal and head and neck malignancies among others, with a number of publications in international peer-reviewed journals.

Education

  • FRCR (Clinical Oncology) (UK)
  • MD (Duke-NUS Medical School)
  • Bachelor of Dental Surgery (National University of Singapore)

Professional Appointments and Committee Memberships

  • Consultant, Division of Radiation Oncology, NCCS
  • Fellow (Clinical Oncology), Royal College of Radiologists

Awards

Research Interests

Publications

  • Network meta-analysis of chemotherapy in nasopharyngeal carcinoma (MAC-NPC): An update on 8221 patients Claire Petit, Anne WM Lee, Alexandra Carmel, Wai Tong Ng, Jun Ma, Anthony TC Chan, Ruey-Long Hong, Ming-Yuan Chen, Lei Chen, Guopei Zhu, Wen-Fei Li, Sharon Poh, Roger Ngan, Hai-Qiang Mai, Pei-Yu Huang, Li Zhang, George Fountzilas, Jean Bourhis, Jean-Pierre Pignon, Pierre Blanchard Journal of Clinical Oncology, May 2020, 38(15)
  • International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma Lee AW, Ng WT, Pan JJ, Chiang CL, Poh SS, Choi HC, Ahn YC, AlHussain H, Corry J, Grau C, Grégoire V, Harrington KJ, Hu CS, Kwong DL, Langendijk JA, Le QT, Lee NY, Lin JC, Lu TX, Mendenhall WM, O'Sullivan B, Ozyar E, Peters LJ, Rosenthal DI, Sanguineti G, Soong YL, Tao Y, Yom SS, Wee JT Int J Radiat Oncol Biol Phys, Jul 2019, 105(3)
  • Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials Chen YP, Tang LL, Yang Q, Poh SS, Hui EP, Chan ATC, Ong WS, Tan T, Wee J, Li WF, Chen L, Ma BBY, Tong M, Tan SH, Cheah SL, Fong KW, Sommat K, Soong YL, Guo Y, Lin AH, Sun Y, Hong MH, Cao SM, Chen MY, Ma J Clin. Cancer Res., Feb 2018, 24(8)
  • International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma Anne W.Lee, Wai Tong Ng, Jian Ji Pan, Sharon S.Poh, Yong Chan Ahn, Hussain AlHussain, June Corry, CaiGrau, Vincent Grégoire, Kevin J.Harrington, Chao Su Hu, Dora L.Kwong, Johannes A.Langendijk, Quynh Thu Le, Nancy Y.Lee, Jin Ching Lin, Tai Xiang Lu, William M.Mendenhall, Joseph T.Wee Radiotherapy and Oncology, Nov 2017, 126(1)

Research Trials